tiprankstipranks
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
Want to see AAPG full AI Analyst Report?

Ascentage Pharma Group International Unsponsored ADR (AAPG) Income Statement

26 Followers

Ascentage Pharma Group International Unsponsored ADR Income Statement

Last quarter (Q4 2025), Ascentage Pharma Group International Unsponsored ADR's total revenue was ¥334.13M, an increase of 321.44% from the same quarter last year. In Q4, Ascentage Pharma Group International Unsponsored ADR's net income was ¥-639.96M. See Ascentage Pharma Group International Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 558.48M¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M
Gross Profit
¥ 426.75M¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M
Operating Expenses
¥ 1.61B¥ 1.32B¥ 1.06B¥ 1.04B¥ 894.42M
Depreciation and Amortization
¥ 84.12M¥ 93.17M¥ 93.19M¥ 47.42M¥ 17.18M
EBITDA
¥ -1.10B¥ -237.63M¥ -743.61M¥ -786.97M¥ -798.34M
Operating Income
¥ -1.18B¥ -369.73M¥ -872.64M¥ -849.81M¥ -869.84M
Other Income/Expenses
¥ -23.21M¥ -25.52M¥ -60.23M¥ -37.36M¥ 37.59M
Pretax Income
¥ -1.20B¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M
Net Income
¥ -1.21B¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M
Per Share Metrics
Basic EPS
¥ -13.56¥ -5.36¥ -52.48¥ -53.60¥ -49.12
Diluted EPS
¥ -13.56¥ -5.36¥ -52.48¥ -53.60¥ -49.12
Weighted Average Shares Outstanding
89.03M 75.52M 17.64M 16.48M 15.91M
Weighted Average Shares Outstanding (Diluted)
89.03M 75.52M 17.64M 16.48M 15.91M
Currency in CNY

Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History